DD298049A5 - Doppelt beschichtete granulate - Google Patents

Doppelt beschichtete granulate Download PDF

Info

Publication number
DD298049A5
DD298049A5 DD90343841A DD34384190A DD298049A5 DD 298049 A5 DD298049 A5 DD 298049A5 DD 90343841 A DD90343841 A DD 90343841A DD 34384190 A DD34384190 A DD 34384190A DD 298049 A5 DD298049 A5 DD 298049A5
Authority
DD
German Democratic Republic
Prior art keywords
granules
coated
coating
preparation
enteric
Prior art date
Application number
DD90343841A
Other languages
German (de)
English (en)
Inventor
Dagmar Wirth
Christian Bucher
Original Assignee
����`��@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ����`��@���k�� filed Critical ����`��@���k��
Publication of DD298049A5 publication Critical patent/DD298049A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Glanulating (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Detergent Compositions (AREA)
DD90343841A 1989-09-07 1990-09-05 Doppelt beschichtete granulate DD298049A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH324589 1989-09-07

Publications (1)

Publication Number Publication Date
DD298049A5 true DD298049A5 (de) 1992-02-06

Family

ID=4251793

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343841A DD298049A5 (de) 1989-09-07 1990-09-05 Doppelt beschichtete granulate

Country Status (21)

Country Link
US (1) US5096717A (fr)
EP (1) EP0421921B1 (fr)
JP (1) JP3009713B2 (fr)
KR (1) KR910005852A (fr)
AT (1) ATE104856T1 (fr)
AU (1) AU623036B2 (fr)
CA (1) CA2024631C (fr)
DD (1) DD298049A5 (fr)
DE (1) DE59005517D1 (fr)
DK (1) DK0421921T3 (fr)
ES (1) ES2052228T3 (fr)
FI (1) FI93169C (fr)
HU (1) HU207447B (fr)
IE (1) IE63668B1 (fr)
IL (1) IL95558A (fr)
MX (1) MX22254A (fr)
NO (1) NO176646C (fr)
NZ (1) NZ235187A (fr)
PH (1) PH27186A (fr)
PT (1) PT95209B (fr)
ZA (1) ZA907100B (fr)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520119A1 (fr) * 1991-06-17 1992-12-30 Spirig Ag Pharmazeutische Präparate Composition à base de diclofenac pour l'administration orale
US6764697B1 (en) * 1991-06-27 2004-07-20 Alza Corporation System for delaying drug delivery up to seven hours
JPH06511237A (ja) * 1991-07-24 1994-12-15 コ、トーマス　サイ　イーング 治療用組成物およびその製造方法
SK279589B6 (sk) * 1991-11-22 1999-01-11 Procter And Gamble Pharmaceuticals Farmaceutický prípravok s retardovaným uvoľňovaním
EP0550385A1 (fr) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Compositions pharmaceutiques orales contenant des dérivés d'acide méthane-diphosphonique et des éthers 18-couronne-6
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5472712A (en) * 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5681585A (en) * 1991-12-24 1997-10-28 Euro-Celtique, S.A. Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
FR2687291B1 (fr) * 1992-02-17 1994-06-03 Sfbd Vivis Aliment pour sportif et son procede de fabrication.
TW237386B (fr) * 1992-04-15 1995-01-01 Ciba Geigy
US5286495A (en) * 1992-05-11 1994-02-15 University Of Florida Process for microencapsulating cells
IT1260505B (it) * 1992-06-01 1996-04-09 Poli Ind Chimica Spa Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
DE4236090C1 (de) * 1992-10-26 1994-01-05 Asta Medica Arzneimittel Pharmazeutische Zubereitung für die Fluoridionen-Versorgung
US5993860A (en) * 1993-06-17 1999-11-30 Venture Lending NSADI delivery employing a powdered hydrocolloid gum obtainable from higher plants
US5431920A (en) * 1993-09-21 1995-07-11 Merck Frosst, Canada, Inc. Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
US5766623A (en) * 1996-03-25 1998-06-16 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University Compactable self-sealing drug delivery agents
DE19637082A1 (de) 1996-09-12 1998-03-19 Boehringer Mannheim Gmbh Schnellzerfallende Pellets
US5788987A (en) * 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
US5891474A (en) 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
KR100400053B1 (ko) * 1997-06-11 2003-09-29 더 프록터 앤드 갬블 캄파니 향상된 상부 위장관 안전용 필름 피복 정제
EP1009387B1 (fr) 1997-07-02 2006-04-12 Euro-Celtique S.A. Formulations de tramadol stabilisees a liberation prolongee
US20020035071A1 (en) * 1997-07-08 2002-03-21 Josef Pitha Mimicking the metabolic effects of caloric restriction by administration of glucose antimetabolites
US20060116330A1 (en) * 1997-07-08 2006-06-01 The Iams Company Methods of mimicking the metabolic effects of caloric restriction by administration of mannoheptulose
US8563522B2 (en) * 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US6197331B1 (en) 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US7008645B2 (en) * 1998-07-14 2006-03-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of inhibiting restenosis using bisphosphonates
IL125336A0 (en) 1998-07-14 1999-03-12 Yissum Res Dev Co Compositions for inhibition and treatment of restinosis
US6984400B2 (en) * 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
US6794536B1 (en) 1998-12-10 2004-09-21 Aesqen, Inc. Method for preparation of disodium pamidronate
US6160165A (en) 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
AR021347A1 (es) 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
WO2001032185A1 (fr) * 1999-11-02 2001-05-10 Cipla Ltd. Composition pharmaceutique renfermant au moins un acide bisphosphonique ou un de ses sels et son procede de preparation
PL196485B1 (pl) * 2000-05-11 2008-01-31 Inst Farmaceutyczny Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania
CA2440641A1 (fr) * 2001-03-13 2002-09-19 Anand R. Baichwal Formes pharmaceutiques chronotherapeutiques contenant un glucocorticosteroide
CA2372450A1 (fr) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Preparation injectable liquide de pamidronate disodique
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
US8168170B2 (en) * 2002-10-03 2012-05-01 The Procter And Gamble Company Compositions having an inner core and at least three surrounding layers
US20060051407A1 (en) * 2003-06-27 2006-03-09 Yoram Richter Method of treating ischemia-reperfusion injury
US10517883B2 (en) * 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
NZ545921A (en) * 2003-09-19 2009-09-25 Penwest Pharmaceuticals Co Delayed released dosage forms
US20050118267A1 (en) * 2003-09-19 2005-06-02 Penwest Pharmaceuticals Co. Chronotherapeutic dosage forms
US8894991B2 (en) * 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
SI21637A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtska oblika z nadzorovanim sproščanjem
EP1781258A1 (fr) * 2004-08-20 2007-05-09 Mepha AG Formulations de bisphosphonates
JP4938006B2 (ja) * 2005-05-31 2012-05-23 ザ・アイムス・カンパニー ネコ科動物プロバイオティク・ビフィドバクテリア
AU2006253006B8 (en) * 2005-05-31 2011-09-15 Alimentary Health Ltd Feline probiotic Lactobacilli
US7473684B2 (en) 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
EP2124966B1 (fr) 2007-02-01 2015-09-09 IAMS Europe B.V. Procédé pour réduire l'inflammation et le stress chez un mammifère en utilisant de glucose, d'avocat ou d'extraits d'avocat
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
DE102009033621A1 (de) 2009-07-17 2011-01-20 Add Technologies Ltd. Trennschichten für pharmazeutische Zubereitungen zur Verhinderung von Wechselwirkungen zwischen Arzneistoffen und pharmazeutisch-technologischen Hilfsstoffen
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US8663671B2 (en) 2009-11-05 2014-03-04 Philip Morris Usa Inc. Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity
US9993427B2 (en) 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture
CA2936746C (fr) 2014-10-31 2017-06-27 Purdue Pharma Methodes et compositions destinees au traitement du trouble de deficit d'attention
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7813246L (sv) * 1978-12-22 1980-06-23 Haessle Ab Fast farmaceutisk beredning innehallande kroppar med flera ytskikt
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition
US4639338A (en) * 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4983401A (en) * 1989-05-22 1991-01-08 Kinaform Technology, Inc. Sustained release pharmaceutical preparations having pH controlled membrane coatings

Also Published As

Publication number Publication date
AU6228390A (en) 1991-03-14
PT95209B (pt) 1998-06-30
PT95209A (pt) 1991-05-22
CA2024631A1 (fr) 1991-03-08
NO176646B (no) 1995-01-30
HU207447B (en) 1993-04-28
NO903892L (no) 1991-03-08
ES2052228T3 (es) 1994-07-01
FI904341A0 (fi) 1990-09-03
EP0421921B1 (fr) 1994-04-27
JPH0399016A (ja) 1991-04-24
IE63668B1 (en) 1995-05-31
IL95558A (en) 1995-08-31
HUT59008A (en) 1992-04-28
DE59005517D1 (de) 1994-06-01
AU623036B2 (en) 1992-04-30
FI93169C (fi) 1995-03-10
ZA907100B (en) 1991-05-29
JP3009713B2 (ja) 2000-02-14
FI93169B (fi) 1994-11-30
EP0421921A1 (fr) 1991-04-10
ATE104856T1 (de) 1994-05-15
NO903892D0 (no) 1990-09-06
NO176646C (no) 1995-05-10
NZ235187A (en) 1992-03-26
KR910005852A (ko) 1991-04-27
PH27186A (en) 1993-04-16
DK0421921T3 (da) 1994-05-30
MX22254A (es) 1993-12-01
HU905812D0 (en) 1991-03-28
US5096717A (en) 1992-03-17
IE903239A1 (en) 1991-03-13
CA2024631C (fr) 2000-11-21
IL95558A0 (en) 1991-06-30

Similar Documents

Publication Publication Date Title
EP0421921B1 (fr) Granulés doubles revêtus
DE60032749T2 (de) Stabilisierte pharmazeutische zusammensetzung enthaltend einen nichtsteroiden entzündungshemmenden wirkstoff und prostaglandin
JP3198337B2 (ja) 酸不安定性ベンゾイミダゾールを含有する新規組成物及びその製造方法
DE3751851T2 (de) Verwendung von spezifischem Kernmaterial und Schichten zur Herstellung pharmazeutischer Formulierungen, die stabil gegen die Verfärbung säurelabiler Verbindungen sind
US20110008426A1 (en) Modified release pharmaceutical compositions comprising mycophenolate and processes thereof
CA2268868C (fr) Forme posologique de bisacodyl comprenant plusieurs enrobages polymeres enteriques pous assurer l'apport dans le colon
EP0566535B1 (fr) Compositions à base d'acides méthanediphosphoniques et d'échangeurs d'ions
US20030086970A1 (en) Anti-inflammatory pharmaceutical formulations
JPH05500674A (ja) 医薬製剤
JPH07165584A (ja) 二重層オキカルバゼピン錠剤
NO170912B (no) Fremgangsmaate for fremstilling av en fast, holdbar administreringsform
JPH11506432A (ja) 結腸送達のためのビサコジル投与形態
NZ202140A (en) Delayed release nitrofurantoin tablets
HUT52369A (en) New form of mediacament
EP1315481A1 (fr) Medicament pour le traitement de maladies intestinales
CN114828832A (zh) 用于治疗和预防疾病的剂型
US20140287037A1 (en) Extended-release topiramate capsules
CH675537A5 (fr)
US20070154550A1 (en) Pharmaceutical composition comprising anticonvulsant with taste mask coating
US20150265544A1 (en) Extended-release topiramage capsules
WO2001032185A1 (fr) Composition pharmaceutique renfermant au moins un acide bisphosphonique ou un de ses sels et son procede de preparation
US20220054452A1 (en) Duloxetine sprinkles
IL301337A (en) Multiparticulate pharmaceutical preparations containing deuterabenzene
JPH0873345A (ja) 医薬製剤
JPS62263124A (ja) 経口投与製剤

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee